港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

東陽光藥

43.980

+0.3400.78%

成交量：8.46萬

成交額：371.29萬

市值：253.32億

市盈率：21.14

高：44.080

開：43.660

低：43.500

收：43.640

52周最高：62.300

52周最低：39.800

股本：5.76億

香港流通股本：1.12億

量比：0.28

換手率：0.08%

股息：- -

股息率：- -

每股收益(LYR):2.081

淨資產收益率：5.87%

總資產收益率：3.32%

市淨率：2.60

市盈率(LYR):21.14

市銷率: 5.94

資料載入中...

總覽公司新聞資訊公告

東陽光藥03月06日主力淨流入48.8萬元散户資金拋售

AI 製藥競速開啓！禮來帶頭，全行業加速佈局

每日沽空追蹤 | 東陽光藥 03月05日沽空量成交1.58萬股，沽空比例為7.72%

國內AI製藥再迎來該「AI＋RNA」小分子創新藥完成頭例患者給藥

每日沽空追蹤 | 東陽光藥 03月04日沽空量成交4.31萬股，沽空比例為8.61%

東陽光藥創歷史新低

廣東東陽光藥業股份有限公司（06887）2月無新增發行或股份變動，股本維持穩定

每日沽空追蹤 | 東陽光藥 03月02日沽空量成交12.42萬股，沽空比例為31.73%

開年數個億元級合作密集落地：AI製藥正加速解構十年十億美元的研發「魔咒」

東陽光藥盤中異動股價大跌5.03%

醫藥行業周報：本周申萬醫藥生物指數上漲0.5% 關注大宗原料藥價格上漲

上海申银万国证...

每日沽空追蹤 | 東陽光藥 02月27日沽空量成交1.9萬股，沽空比例為6.64%

每日沽空追蹤 | 東陽光藥 02月25日沽空量成交1.37萬股，沽空比例為3.27%

東陽光擬收購東數一號控制權，280億元秦淮數據資產或併入上市公司

國內首款，東陽光藥重磅1類「特效藥」迎來新進展

北京药研汇

東陽光藥：中國國家藥監局受理HEC-648注射液的臨床試驗申請

東陽光藥(06887)：靶向尼帕病毒G蛋白的單克隆抗體新藥HEC-648注射液臨床試驗申請獲中國國家藥品監督管理局受理

東陽光藥02月24日主力淨流出50.3萬元散户資金買入

307個藥品超厲害！15億注射劑首次封王，正大天晴猛增357%，東陽光藥、仁合益康大爆發

每日沽空追蹤 | 東陽光藥 02月23日沽空量成交5500股，沽空比例為5.14%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06887/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06887\",,,,,undefined,":{"symbol":"06887","market":"HK","secType":"STK","nameCN":"東陽光藥","latestPrice":43.98,"timestamp":1775808560007,"preClose":43.64,"halted":0,"volume":84614,"delay":0,"changeRate":0.007791017415215314,"floatShares":112000000,"shares":576000000,"eps":2.080908,"marketStatus":"休市中","change":0.34,"latestTime":"04-10 16:09:20","open":43.66,"high":44.08,"low":43.5,"amount":3712919,"amplitude":0.013291,"askPrice":43.98,"askSize":1000,"bidPrice":43.8,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.524,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776043800000},"marketStatusCode":7,"adr":0,"listingDate":1754496000000,"exchange":"SEHK","adjPreClose":43.64,"openAndCloseTimeList":[[1775784600000,1775793600000],[1775797200000,1775808000000]],"volumeRatio":0.2793953905989707,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06887\",,,,,undefined,":{"symbol":"06887","floatShares":112000000,"roa":"3.32%","roe":"5.87%","lyrEps":2.080908,"volumeRatio":0.2793953905989707,"shares":576000000,"dividePrice":0,"high":44.08,"amplitude":0.013291,"preClose":43.64,"low":43.5,"week52Low":39.8,"pbRate":"2.60","psRate":"5.94","week52High":62.3,"institutionHeld":0,"latestPrice":43.98,"committee":-0.666667,"eps":2.080908,"divideRate":0,"volume":84614,"delay":0,"ttmEps":0.524,"open":43.66,"prevYearClose":45.6,"prevWeekClose":43.86,"prevMonthClose":45,"prevQuarterClose":45,"fiveDayClose":45,"twentyDayClose":42.16,"sixtyDayClose":43.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06887\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"06887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06887\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06887","date":"2026-04-10","current":83.931298,"percent":0.256098,"low":26.481481,"twenty":45.357433,"median":48.167987,"eighty":51.862824,"high":87.951651,"avg":48.70124,"sd":4.955409,"marketCap":25332728355},"quantilePoints":[{"date":"2025-08-08","current":87.951651,"twenty":38.775515,"median":57.216566,"eighty":75.657617,"marketCap":46410789719},{"date":"2025-08-15","current":53.544743,"twenty":50.854913,"median":50.910211,"eighty":53.207453,"marketCap":28212434399},{"date":"2025-08-22","current":46.053295,"twenty":48.528483,"median":50.885695,"eighty":53.358103,"marketCap":24189138855},{"date":"2025-08-29","current":48.593903,"twenty":46.280797,"median":49.970466,"eighty":52.516937,"marketCap":25645423745},{"date":"2025-09-05","current":50.421125,"twenty":47.199187,"median":49.797857,"eighty":51.668677,"marketCap":26583369945},{"date":"2025-09-12","current":49.629542,"twenty":47.419761,"median":49.970466,"eighty":51.668677,"marketCap":26213128024},{"date":"2025-09-19","current":54.62816,"twenty":48.205808,"median":50.411246,"eighty":53.54124,"marketCap":28832802350},{"date":"2025-09-26","current":53.850125,"twenty":48.404456,"median":50.853346,"eighty":54.601279,"marketCap":28348411270},{"date":"2025-10-03","current":53.088089,"twenty":48.593903,"median":50.910211,"eighty":54.493754,"marketCap":28013950763},{"date":"2025-10-10","current":52.114945,"twenty":48.663506,"median":51.880943,"eighty":54.471659,"marketCap":27460360958},{"date":"2025-10-17","current":51.235542,"twenty":48.675057,"median":51.667489,"eighty":54.265854,"marketCap":26975969878},{"date":"2025-10-24","current":51.392091,"twenty":48.841643,"median":51.235542,"eighty":53.929637,"marketCap":27068234846},{"date":"2025-10-31","current":50.069287,"twenty":49.32788,"median":50.982905,"eighty":53.853315,"marketCap":26410846952},{"date":"2025-11-07","current":53.644815,"twenty":49.627824,"median":51.208128,"eighty":53.746971,"marketCap":28279212544},{"date":"2025-11-14","current":53.755029,"twenty":49.70171,"median":51.476684,"eighty":54.315924,"marketCap":28417609996},{"date":"2025-11-21","current":46.009908,"twenty":49.627824,"median":51.313817,"eighty":54.001174,"marketCap":24311818941},{"date":"2025-11-28","current":50.562563,"twenty":49.32788,"median":51.158242,"eighty":53.853315,"marketCap":26814506185},{"date":"2025-12-05","current":49.62909,"twenty":48.806915,"median":50.946558,"eighty":53.793067,"marketCap":26364714468},{"date":"2025-12-12","current":45.875244,"twenty":48.689091,"median":50.853346,"eighty":53.708932,"marketCap":24415617029},{"date":"2025-12-19","current":48.167088,"twenty":48.455966,"median":50.812822,"eighty":53.658169,"marketCap":25695793454},{"date":"2025-12-24","current":47.090792,"twenty":48.188424,"median":50.667849,"eighty":53.624801,"marketCap":25199869253},{"date":"2026-01-02","current":47.915151,"twenty":47.916975,"median":50.562563,"eighty":53.544743,"marketCap":25741925938},{"date":"2026-01-09","current":46.425642,"twenty":47.58113,"median":50.411246,"eighty":53.527229,"marketCap":25003806197},{"date":"2026-01-16","current":46.054632,"twenty":47.232705,"median":50.329975,"eighty":53.374504,"marketCap":24884593070},{"date":"2026-01-23","current":50.623376,"twenty":47.090792,"median":50.178609,"eighty":53.359475,"marketCap":27326969797},{"date":"2026-01-30","current":45.230483,"twenty":47.047797,"median":49.970466,"eighty":53.088089,"marketCap":24527453077},{"date":"2026-02-06","current":44.437932,"twenty":46.420917,"median":49.799183,"eighty":52.900313,"marketCap":24158792439},{"date":"2026-02-13","current":45.701196,"twenty":46.174063,"median":49.62909,"eighty":52.681598,"marketCap":24988278874},{"date":"2026-02-20","current":45.935922,"twenty":46.148611,"median":49.625248,"eighty":52.6697,"marketCap":25080444034},{"date":"2026-02-27","current":44.769714,"twenty":46.084498,"median":49.275965,"eighty":52.612192,"marketCap":24711783396},{"date":"2026-03-06","current":44.628573,"twenty":45.995306,"median":49.048903,"eighty":52.550074,"marketCap":24435287917},{"date":"2026-03-13","current":43.816568,"twenty":45.814099,"median":48.917029,"eighty":52.490531,"marketCap":24101189214},{"date":"2026-03-20","current":43.562623,"twenty":45.547933,"median":48.680907,"eighty":52.290256,"marketCap":23870776315},{"date":"2026-03-27","current":45.633996,"twenty":45.288204,"median":48.557891,"eighty":52.021344,"marketCap":24942196295},{"date":"2026-04-02","current":46.003101,"twenty":45.37598,"median":48.313634,"eighty":51.876413,"marketCap":25264774353},{"date":"2026-04-10","current":45.773794,"twenty":45.357433,"median":48.167987,"eighty":51.862824,"marketCap":25332728355}],"updateTime":1775936207676},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06887\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617680489","title":"東陽光藥03月06日主力淨流入48.8萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2617680489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617680489?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 16:16","pubTimestamp":1772784962,"startTime":"0","endTime":"0","summary":"03月06日, 东阳光药股价涨4.84%，报收42.42元，成交金额1607.4万元，换手率0.34%，振幅4.70%，量比1.09。东阳光药今日主力资金净流入48.8万元，上一交易日主力净流出73.3万元。该股近5个交易日下跌1.03%，主力资金累计净流入249.6万元；近20日主力资金累计净流入412.0万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306162203a6aa300d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306162203a6aa300d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617638504","title":"AI 製藥競速開啓！禮來帶頭，全行業加速佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2617638504","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617638504?lang=zh_tw&edition=fundamental","pubTime":"2026-03-06 11:00","pubTimestamp":1772766028,"startTime":"0","endTime":"0","summary":"近日，礼来宣布，AI制药工厂LillyPod已投入运行。根据合作备忘录，镁睿化学将基于其高通量自动化实验室和AI技术平台，为默克中国提供化学合成及相关服务，加快分子合成速度，缩短产品开发周期。BMS与AI制药公司insitro合作部署，用于ALS新药小分子发现与优化。未来，随着礼来AI制药工厂的投运，以及大批企业合作的推进，制药行业的研发范式预计将实现从“人力密集型”到“算力密集型”的根本性变革。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110307a6a9226e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110307a6a9226e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","01477","BK1593","BK1515","06887","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617542549","title":"每日沽空追蹤 | 東陽光藥 03月05日沽空量成交1.58萬股，沽空比例為7.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617542549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617542549?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 16:30","pubTimestamp":1772699438,"startTime":"0","endTime":"0","summary":"东阳光药北京时间03月05日，跌1.94%，卖空量成交1.58万股，较上一交易日减少89.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163545a6a5db17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305163545a6a5db17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617573087","title":"國內AI製藥再迎來該「AI＋RNA」小分子創新藥完成頭例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2617573087","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617573087?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 09:48","pubTimestamp":1772675280,"startTime":"0","endTime":"0","summary":"近年来AI制药兴起，全球AI制药企业超350家，国内不少于100家。3月2日，晶泰科技孵化企业ReviR宣布，其小分子药物管线RTX-117完成头例受试者给药，正式进入临床开发阶段，有望为腓骨肌萎缩症、白质消融性白质脑病等神经系统疾病患者提供治疗方案。RTX-117结合晶泰科技AI+机器人药物研发平台与ReviR对RNA生物学的理解，通过抑制异常激活的ISR通路，恢复mRNA正常翻译，从分子根源治疗疾病，未来有望拓展至更多适应症。晶泰科技正强化其优势与商业化价值，先后与多家企业达成合作，东阳光药与其成立合资公司，构建长期、深度绑定的技术共生关系。有机构表示，AI技术正改变新药研发格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305100816a44d84db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260305100816a44d84db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1574","06887","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617592407","title":"每日沽空追蹤 | 東陽光藥 03月04日沽空量成交4.31萬股，沽空比例為8.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617592407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617592407?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 16:30","pubTimestamp":1772613037,"startTime":"0","endTime":"0","summary":"东阳光药北京时间03月04日，跌0.63%，卖空量成交4.31万股，较上一交易日减少71.57%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163602a6a15219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163602a6a15219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617239592","title":"東陽光藥創歷史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2617239592","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617239592?lang=zh_tw&edition=fundamental","pubTime":"2026-03-04 13:43","pubTimestamp":1772602983,"startTime":"0","endTime":"0","summary":"格隆汇3月4日丨东阳光药(06887.HK)跌2.41%，报40.5200港元，股价创历史新低，总市值233.66亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304135458a6a0b3ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304135458a6a0b3ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163236597","title":"廣東東陽光藥業股份有限公司（06887）2月無新增發行或股份變動，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1163236597","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163236597?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 17:29","pubTimestamp":1772530180,"startTime":"0","endTime":"0","summary":"2026年3月3日，广东东阳光药业股份有限公司发布截至2026年2月28日的股份变动月报表。公告显示，截至报告期末，公司注册股本为人民币576,656,047元，包含H股与内资股。其中H股法定/注册股份数为112,712,832股，内资股法定/注册股份数为463,943,215股，整体保持不变。公告同时披露，公司并无关于员工期权、可换股票据或其他相关权证的任何新增或变动，亦无任何购回、注销行为。公告由董事张英俊签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616336787","title":"每日沽空追蹤 | 東陽光藥 03月02日沽空量成交12.42萬股，沽空比例為31.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616336787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616336787?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 16:30","pubTimestamp":1772440241,"startTime":"0","endTime":"0","summary":"东阳光药北京时间03月02日，跌2.1%，卖空量成交12.42万股，较上一交易日减少2.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163630a730c9e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163630a730c9e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616133675","title":"開年數個億元級合作密集落地：AI製藥正加速解構十年十億美元的研發「魔咒」","url":"https://stock-news.laohu8.com/highlight/detail?id=2616133675","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616133675?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 11:42","pubTimestamp":1772422976,"startTime":"0","endTime":"0","summary":"而更早之前，东阳光药与晶泰科技成立合资公司，计划投入数亿元共建“AI+机器人”联合实验室；英硅智能与齐鲁制药则达成总额达9.31亿港元的战略合作，聚焦心血管代谢疾病的靶点开发。密集的合作事件背后，AI制药已从概念验证阶段，迈入与传统药企深度融合的产业落地期。长期的工具使用与相互了解，为当下数亿港元级别的共同研发合作奠定了信任基础。此次合作，双方聚焦于心血管代谢疾病的特定靶点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302114520a72fbfe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302114520a72fbfe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","01477","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616806411","title":"東陽光藥盤中異動 股價大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616806411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616806411?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 09:54","pubTimestamp":1772416481,"startTime":"0","endTime":"0","summary":"2026年03月02日早盘09时54分，东阳光药股票出现波动，股价急速下挫5.03%。截至发稿，该股报40.740港元/股，成交量8.96万股，换手率0.08%，振幅3.26%。资金方面，该股资金流入220.175万港元，流出104.203万港元。东阳光药股票所在的药品行业中，整体跌幅为0.61%。其相关个股中，宝济药业-B、金嗓子、开拓药业-B涨幅较大，振幅较大的相关个股有宝济药业-B、君圣泰医药-B、劲方医药-B，振幅分别为12.20%、8.66%、6.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030209544197a791ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030209544197a791ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616336202","title":"醫藥行業周報：本周申萬醫藥生物指數上漲0.5% 關注大宗原料藥價格上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2616336202","media":"上海申银万国证...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616336202?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 00:00","pubTimestamp":1772380800,"startTime":"0","endTime":"0","summary":"市场表现：本周申万医药生物指数上涨0.5%，同期上证指数上涨1.98%，万得全A上涨3.2%。本周医药生物指数在31 个申万一级子行业中表现排名第25。CHMP 建议欧盟委员会批准赖脯胰岛素作为Humalog 的生物类似药上市，用于治疗成人和儿童的糖尿病；建议批准门冬胰岛素作为NovoRapid 的生物类似药上市，用于治疗成人、青少年和1 岁及以上儿童的糖尿病。预计EC 将做出最终审理决定，届时获批产品将在欧盟成员国及挪威、冰岛、列支敦士登获准上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302170111a4417050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302170111a4417050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03933","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614830852","title":"每日沽空追蹤 | 東陽光藥 02月27日沽空量成交1.9萬股，沽空比例為6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614830852","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614830852?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 16:30","pubTimestamp":1772181039,"startTime":"0","endTime":"0","summary":"东阳光药北京时间02月27日，涨4.18%，卖空量成交1.9万股，较上一交易日减少63.04%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163558a725f5ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163558a725f5ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614062198","title":"每日沽空追蹤 | 東陽光藥 02月25日沽空量成交1.37萬股，沽空比例為3.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614062198","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614062198?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 16:30","pubTimestamp":1772008242,"startTime":"0","endTime":"0","summary":"东阳光药北京时间02月25日，跌3.98%，卖空量成交1.37万股，较上一交易日减少54.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163607a71d5cc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163607a71d5cc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614062902","title":"東陽光擬收購東數一號控制權，280億元秦淮數據資產或併入上市公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2614062902","media":"读创","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614062902?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 15:19","pubTimestamp":1772003951,"startTime":"0","endTime":"0","summary":"2月24日晚间，东阳光发布公告，正在筹划通过发行股份的方式收购宜昌东数一号投资有限责任公司控制权，并募集配套资金。据悉，东数一号通过全资孙公司宜昌东数三号投资有限责任公司控制秦淮数据经营主体的100%股权，东阳光此举意味着拟将秦淮数据正式揽入上市公司体系内。今年1月，东阳光曾公告收购秦淮数据中国100%股权交易交割完成，该交易总金额为280亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225152516a71d0f7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225152516a71d0f7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614270861","title":"國內首款，東陽光藥重磅1類「特效藥」迎來新進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2614270861","media":"北京药研汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614270861?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 08:03","pubTimestamp":1771977824,"startTime":"0","endTime":"0","summary":"根据东阳光药新闻稿公示，HEC-648注射液是一款靶向尼帕病毒G蛋白的全人源单克隆抗体，具体适应症暂未披露。2023年底，东阳光药与中国科学院武汉病毒所签订合作协议，将其开发成为1类创新药物。目前，该药物是国内首款进入临床试验申请审评阶段的针对尼帕病毒的特异性治疗药物。根据披露信息，在尼帕病毒感染的高致死性重症动物模型试验中，该抗体药物显示出100%的预防性死亡保护率以及超80%的治疗性死亡保护率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225085920a4c4d31c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225085920a4c4d31c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157927809","title":"東陽光藥：中國國家藥監局受理HEC-648注射液的臨床試驗申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1157927809","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157927809?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 17:38","pubTimestamp":1771925889,"startTime":"0","endTime":"0","summary":"近日，东阳光药宣布其研发的HEC-648注射液临床试验申请已获中国国家药品监督管理局正式受理。这一进展标志着该创新药物正式进入临床审评阶段，为后续研发工作奠定重要基础。HEC-648注射液作为公司重点推进的创新药项目，其审评进程备受市场关注。此次受理不仅体现了监管机构对该公司研发能力的认可，也为其未来产品管线注入新的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","06887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613670791","title":"東陽光藥(06887)：靶向尼帕病毒G蛋白的單克隆抗體新藥HEC-648注射液臨床試驗申請獲中國國家藥品監督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2613670791","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613670791?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 17:37","pubTimestamp":1771925847,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东阳光药(06887)发布公告，2026年2月24日，中国国家药品监督管理局药品审评中心(“药品审评中心”)正式受理本集团提交的靶向尼帕病毒G蛋白的单克隆抗体新药HEC-648注射液临床试验申请，预计将于2026年正式启动I期临床研究。本集团秉持“科学创制新药，品质健康生活”的使命，立项研发尼帕病毒抗体药物作为战略储备，既是布局新发突发传染病防控、践行行业价值，也是助力国家筑牢生物安全与公共卫生防线、服务“一体化健康”战略、提升医药核心技术自主可控与全球公共卫生治理话语权的关键行动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"东阳光药(06887)：靶向尼帕病毒G蛋白的单克隆抗体新药HEC-648注射液临床试验申请获中国国家药品监督管理局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06887","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614618708","title":"東陽光藥02月24日主力淨流出50.3萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614618708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614618708?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 16:15","pubTimestamp":1771920928,"startTime":"0","endTime":"0","summary":"02月24日, 东阳光药股价跌0.92%，报收43.22元，成交金额513.5万元，换手率0.11%，振幅4.36%，量比0.51。东阳光药今日主力资金净流出50.3万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.90%，主力资金累计净流出168.8万元；近20日主力资金累计净流入368.2万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161704a71908c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161704a71908c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613171858","title":"307個藥品超厲害！15億注射劑首次封王，正大天晴猛增357%，東陽光藥、仁合益康大爆發","url":"https://stock-news.laohu8.com/highlight/detail?id=2613171858","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613171858?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 16:07","pubTimestamp":1771920453,"startTime":"0","endTime":"0","summary":"307个西药品牌销售额超过1亿元，澳诺(中国)制药、青岛双鲸药业、翰森制药等9个爆款大卖超10亿元；203个过亿品牌有正增长，先声药业、齐鲁制药、正大天晴等16个品牌涨幅超过100%。307个药品卖过亿！石药控股7个过亿品牌合揽超过13亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602241614269541c5aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602241614269541c5aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","03692","02096","06887","01801","09995","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613730314","title":"每日沽空追蹤 | 東陽光藥 02月23日沽空量成交5500股，沽空比例為5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613730314?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 16:30","pubTimestamp":1771835438,"startTime":"0","endTime":"0","summary":"东阳光药北京时间02月23日，涨0.18%，卖空量成交5500股，较上一交易日减少66.87%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163535a4be7ebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163535a4be7ebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}